Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

59 trials with published results (10%)

Research Maturity

310 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

41 terminated out of 610 trials

Success Rate

88.3%

+1.8% vs benchmark

Late-Stage Pipeline

17%

101 trials in Phase 3/4

Results Transparency

19%

59 of 310 completed with results

Key Signals

59 with results88% success41 terminated

Data Visualizations

Phase Distribution

362Total
Not Applicable (215)
Early P 1 (5)
P 1 (9)
P 2 (32)
P 3 (32)
P 4 (69)

Trial Status

Completed310
Unknown106
Recruiting61
Terminated41
Withdrawn34
Not Yet Recruiting28

Trial Success Rate

88.3%

Benchmark: 86.5%

Based on 310 completed trials

Clinical Trials (610)

Showing 20 of 20 trials
NCT02548975CompletedPrimary

Risk Factors for Delirium Following Cardiac Surgery

NCT07114458RecruitingPrimary

Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation Conditions

NCT06963112Phase 1CompletedPrimary

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

NCT07716800Not Yet Recruiting

Predictors of Cognitive Decline and Delirium in Older Women With Ovarian Cancer

NCT02465307Active Not RecruitingPrimary

Intelligent Intensive Care Unit

NCT07710066Not Yet Recruiting

Analysis of Weaning of Analgosedation and Kinetics of Emergence in Critically Ill Patients

NCT03905668Active Not Recruiting

Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future

NCT03182335Active Not Recruiting

Vasopressor SAT Study

NCT05373017Not ApplicableActive Not RecruitingPrimary

Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors

NCT05127265Recruiting

Pervasive Sensing and AI in Intelligent ICU

NCT06192615Phase 3RecruitingPrimary

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

NCT03385993Not ApplicableActive Not RecruitingPrimary

Digital Rehabilitation Environment Augmenting Medical System

NCT07151716Phase 4Completed

Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients

NCT06206473Not ApplicableWithdrawn

Cognitive Dysfunctions Associated With Delirium in Critically-ill ARDS Patients

NCT03743649Phase 2Active Not RecruitingPrimary

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

NCT07641153Not ApplicableRecruiting

VR-Based Cognitive Stimulation Games for Delirium Prevention

NCT06027788Not ApplicableRecruitingPrimary

CTSN Embolic Protection Trial

NCT03317067Phase 3CompletedPrimary

Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial)

NCT02905812Not ApplicableActive Not RecruitingPrimary

Pilot Clinical Trial of an Integrative Intervention to Improve Critically Ill Patients' Delirium and Related Outcomes

NCT07577726Not Yet Recruiting

Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery

Scroll to load more

Research Network

Activity Timeline